Cancer-Attributable Mortality among People with Treated Human Immunodeficiency Virus Infection in North America

Keyphrases

• AIDS/HIV 100%
• North America 100%
• Human Immunodeficiency Virus Infection 100%
• Attributable Mortality 100%
• Population Attributable Fraction 66%
• Antiretroviral Therapy 50%
• AIDS-defining Illness 50%
• Liver Cancer 33%
• Incident Cancer 33%
• Non-Hodgkin Lymphoma 33%
• Lung Cancer 33%
• Mortality Rate 33%
• CD4 Count 33%
• Viral Load 16%
• Decedents 16%
• Proportional Hazards Model 16%
• Attributable Deaths 16%
• Prior Cancer 16%
• Mortality Decline 16%
• Public Health Campaigns 16%
• HIV Cohort 16%
• HIV Risk 16%
• AIDS-related Deaths 16%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Human Immunodeficiency Virus Infection 100%
• Human Immunodeficiency Virus 77%
• Cancer 55%
• Antiretroviral Therapy 33%
• Liver Cancer 22%
• Lung Cancer 22%
• Mortality Rate 22%
• Non-Hodgkin Lymphoma 22%
• Proportional Hazards Model 11%
• High Risk Population 11%
• Public Health 11%
• Human Immunodeficiency Virus Risk Behavior 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Human Immunodeficiency Virus Infection 100%
• HIV 88%
• Liver Cancer 22%
• Mortality Rate 22%
• Nonhodgkin Lymphoma 22%
• Lung Cancer 22%